Medical nutrition: for the dietary management of pulmonary inflammation in patients with sepsis, ali, or ards
Medical nutrition (FSMP)4 registrations
Company: ABBOTT LABORATORIESLast updated:Audience: Licensed health professionals
Registered with the Philippine FDA as a FOOD FOR SPECIAL MEDICAL PURPOSES — for the dietary management of patients under medical supervision. Use with a physician's or dietitian's guidance; it is a food, not a drug.
FDA Philippines registrations
4 current FSMP registrations under the brand Oxepa. Registration status changes;
confirm a product's current status on the FDA verification portal using its FR number.
SPECIALIZED LIQUID NUTRITION WITH EICOSAPENTAENOIC ACID, GAMMA LINOLENIC ACID AND INCREASED ANTIOXIDANTS (FOOD FOR SPECIAL MEDICAL PURPOSE: FOR THE DIETARY MANAGEMENT OF PULMONARY INFLAMMATION IN PATIENTS WITH SEPSIS, ALI, OR ARDS)
Composition
The FDA record names the product type and its registered use, not the full composition. Check the product label for protein, energy, potassium, phosphorus, sodium and fluid per serving.
For the dietary management of pulmonary inflammation in patients with sepsis, ali, or ards
Form
Liquid
Company
ABBOTT LABORATORIES
Issued
June 20, 2026
Valid until
June 12, 2037
FDA risk class
High Risk
Application
Automatic Amendment
SPECIALIZED LIQUID NUTRITION WITH EICOSAPENTEANOIC ACID, GAMMA LINOLENIC ACID AND INCREASED ANTIOXIDANTS (FOOD FOR SPECIAL MEDICAL PURPOSE:FOR THE DIETARY MANAGEMENT OF PULMONARY INFLAMMATION IN PATIENTS WITH SEPSIS, ALI, OR ARDS)
Composition
The FDA record names the product type and its registered use, not the full composition. Check the product label for protein, energy, potassium, phosphorus, sodium and fluid per serving.
For the dietary management of pulmonary inflammation in patients with sepsis, ali, or ards
Form
Liquid
Company
ABBOTT LABORATORIES
Issued
September 9, 2026
Valid until
September 9, 2031
FDA risk class
High Risk
Application
Initial
SPECIALIZED LIQUID NUTRITION WITH EICOSAPENTAENOIC ACID, GAMMA LINOLENIC ACID AND INCREASED ANTIOXIDANTS (FOOD FOR SPECIAL MEDICAL PURPOSE: FOR THE DIETARY MANAGEMENT OF PULMONARY INFLAMMATION IN PATIENTS WITH SEPSIS, ALI, OR ARDS)
Composition
The FDA record names the product type and its registered use, not the full composition. Check the product label for protein, energy, potassium, phosphorus, sodium and fluid per serving.
For the dietary management of pulmonary inflammation in patients with sepsis, ali, or ards
Form
Liquid
Company
ABBOTT LABORATORIES
Issued
August 26, 2026
Valid until
October 17, 2030
FDA risk class
High Risk
Application
Amendment
SPECIALIZED LIQUID NUTRITION WITH EICOSAPENTEANOIC ACID, GAMMA LINOLENIC ACID AND INCREASED ANTIOXIDANTS (FOOD FOR SPECIAL MEDICAL PURPOSE:FOR THE DIETARY MANAGEMENT OF PULMONARY INFLAMMATION IN PATIENTS WITH SEPSIS, ALI, OR ARDS)
Composition
The FDA record names the product type and its registered use, not the full composition. Check the product label for protein, energy, potassium, phosphorus, sodium and fluid per serving.
For the dietary management of pulmonary inflammation in patients with sepsis, ali, or ards
Form
Liquid
Company
ABBOTT LABORATORIES
Issued
August 6, 2025
Valid until
August 6, 2030
FDA risk class
High Risk
Application
Renewal
For health professionals. Data come from the FDA Philippines food-product
registration database and may lag behind the official record. A food-for-special-medical-purposes registration means the product may be sold as a food for the dietary management of patients under medical supervision; it is not a drug approval. Not a substitute for clinical judgment.